financetom
Business
financetom
/
Business
/
Sunrun Q4 Loss Widens, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sunrun Q4 Loss Widens, Revenue Increases
Feb 28, 2025 1:35 AM

04:10 AM EST, 02/28/2025 (MT Newswires) -- Sunrun ( RUN ) reported a Q4 loss late Thursday of $12.51 per diluted share, widening from a loss of $1.60 a year earlier.

Revenue for the quarter ended Dec. 31 was $518.5 million, up from $516.6 million a year earlier.

Analysts surveyed by FactSet expected $538.3 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trading app Robinhood agrees deal with Pluto Capital to tap into AI
Trading app Robinhood agrees deal with Pluto Capital to tap into AI
Jul 1, 2024
(Reuters) - Robinhood Markets ( HOOD ) said on Monday it had bought artificial intelligence-powered investment platform Pluto Capital, adding the trading app to a growing list of companies looking to offer AI tools to customers. Top technology companies are racing to build AI into their products and services. Generative AI, which aims to create human-like interactions by processing vast...
Southern Copper flags progress at key Peru mine, share prices rise
Southern Copper flags progress at key Peru mine, share prices rise
Jul 1, 2024
LIMA, July 1 (Reuters) - Miner Southern Copper will likely finish building its Tia Maria copper project in southern Peru in up to two years and then begin production in 2027 if not sooner, Chief Executive Officer Oscar Gonzalez told local radio broadcaster RPP. Reuters reported on Sunday, citing an internal document, that the long-postponed $1.4 billion project located in...
Why Humacyte Stock Is Trading 15% Higher Monday
Why Humacyte Stock Is Trading 15% Higher Monday
Jul 1, 2024
Humacyte, Inc. ( HUMA ) is moving higher on Monday after receiving the Food and Drug Administration’s Regenerative Medicine Advanced Therapy (RMAT) designation for its Acellular Tissue Engineered Vessel (ATEV). What To Know: This is the biotechnology company’s third time receiving the RMAT designation which is designed to expedite the development and review of therapies for serious conditions. The designation...
Li-Cycle Holdings Plans $75 Million Stock Offering -- Shares Fall
Li-Cycle Holdings Plans $75 Million Stock Offering -- Shares Fall
Jul 1, 2024
01:38 PM EDT, 07/01/2024 (MT Newswires) -- Li-Cycle Holdings' ( LICY ) shares fell 16% in recent trading Monday after the company said last week it entered into a deal to sell up to $75 million of common shares via an at-the-market equity offering program. B. Riley Securities will act as Li-Cycle's ( LICY ) sales agent, or principal, for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved